PHOENIX–(BUSINESS WIRE)–Aug. 18, 2003–Vital Living Inc. (OTCBB: VTLV) today announced that David M. Allen will be joining the Board of Directors of Vital Living.
Mr. Allen, aged 61, has served as Managing Director of Investment Information Services, Ltd., (IISL) since 1991. HSL is a UK limited company providing fundamental and technical research to several private banks in London and a group of high net-worth investors in the UK and the US. Mr. Allen is President of Investment Information Services Inc., (IISLI) a Registered Investment Advisor in Colorado. IISI provides fundamental and technical research to hedge funds and accredited investors. In addition, Mr. Allen serves as the investment consultant to US Tax and Financial Services, Ltd., a firm of accountants and lawyers in London.
Brad Edson, CEO of Vital Living, said, “I am extremely pleased that Mr. Allen has demonstrated his confidence by joining the Board of Vital Living. I look forward to his advice and counsel as we continue in the rapid growth phase of our Company.”
David Allen stated, “I am excited about joining the Board of Vital Living at this very exciting and opportunistic point in the Company’s history. I am confident that I can work closely with the present Board to represent the best interests of the shareholders.”
About David M. Allen
Within three years of completing his studies at Columbia University’s School of General Studies in 1969, Mr. Allen was appointed European Director for Physicians Planning Service Corp., (PPS). He was responsible for serving the financial planning needs of more than four hundred PPS members (physicians and dentists) stationed at US military hospitals throughout Western Europe. Mr. Allen opened offices in Germany, England, Italy and Spain, offering financial services implemented by CPAs to U.S. servicemen and their spouses
In 1977, Mr. Allen moved his family to England where he became a stockbroker/financial advisor for Dean Witter Reynolds. In 1982, he was appointed Managing Director of Dean Witter responsible for England.
In 1984, Mr. Allen left Dean Witter to become a Senior Partner for Capital Asset Management Ltd., a private client portfolio management company in London.
About Vital Living
Vital Living develops and markets evidence-based nutraceuticals formulated by physicians for distribution through physicians. The Company is developing and testing nutraceuticals in collaboration with leading medical experts based on the best available scientific evidence.
Vital Living’s nutraceuticals are designed to be incorporated by physicians into a standard physician/patient program, supported by a specially designed compliance regimen. The Company’s initial area of focus is cardiovascular health, the leading health concern in America affecting 60 million consumers. Essentum(TM) is currently being endorsed and prescribed at the Arizona Heart Institute as part of a comprehensive cardiovascular health program as well as other practitioner offices throughout the United States. Vital Living also owns and operates MAF Bionutritionals, which markets and sells, a variety of impact nutritional products, including Boulder Bar, Phils Bars, Alma Bars, and Nature’s Dose. Vital Living also owns and operates Nature’s Systems Inc., which owns and operates the Christopher Herb line of products. Christophers, which has been operating for over 50 years, markets its line of over 300 products, through various channels, including traditional and mass retail, direct to consumers and practitioners.
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the company’s ability to continue to successfully market and provide its products and services and maintain their effectiveness, the continuation of the arrangements with the company’s product development partners, the ability of the company to meet its financial projections, and general economic conditions. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
